9FYJ | pdb_00009fyj

N-terminal domain of human galectin-8 in complex with an alpha-galactoside ligand


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.08 Å
  • R-Value Free: 
    0.150 (Depositor), 0.161 (DCC) 
  • R-Value Work: 
    0.132 (Depositor), 0.148 (DCC) 
  • R-Value Observed: 
    0.133 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.0 of the entry. See complete history


Literature

Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-pi interaction.

Puric, E.Hassan, M.Sjovall, F.Tomasic, T.Pevec, M.Lah, J.Forteza, J.A.Sundin, A.Leffler, H.Nilsson, U.J.Logan, D.T.Anderluh, M.

(2025) Commun Chem 8: 59-59

  • DOI: https://doi.org/10.1038/s42004-025-01458-6
  • Primary Citation of Related Structures:  
    9FYJ

  • PubMed Abstract: 

    Galectin-8 is a tandem-repeat galectin consisting of two distinct carbohydrate recognition domains and is a potential drug target. We have developed a library of galectin-8N inhibitors that exhibit high nanomolar K d values as determined by a competitive fluorescence polarization assay. A detailed thermodynamic analysis of the binding of D-galactosides to galectin-8N by isothermal titration calorimetry reveals important differences in enthalpic and/or entropic contributions to binding. Contrary to expectations, the binding of 2-O-propargyl-D-galactoside was found to strongly increase the binding enthalpy, whereas the binding of 2-O-carboxymethylene-D-galactoside was surprisingly less enthalpy-driven. The results of our work suggest that the ethynyl group can successfully replace the carboxylate group when targeting the water-exposed guanidine moiety of a critical arginine residue. This results in only a minor loss of affinity and an adjusted enthalpic contribution to the overall binding due to non-canonical cation-π interactions, as evidenced by the obtained crystal structure of 2-O-propargyl-D-galactoside in complex with the N-terminal domain of galectin-8. Such an interaction has neither been identified nor discussed to date in a small-molecule ligand-protein complex.


  • Organizational Affiliation
    • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Isoform 1 of Galectin-8
A, B
153Homo sapiensMutation(s): 0 
Gene Names: LGALS8
UniProt & NIH Common Fund Data Resources
Find proteins for O00214 (Homo sapiens)
Explore O00214 
Go to UniProtKB:  O00214
PHAROS:  O00214
GTEx:  ENSG00000116977 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO00214
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
A1IHE (Subject of Investigation/LOI)
Query on A1IHE

Download Ideal Coordinates CCD File 
C [auth A],
E [auth B]
2-[[(2~{R},3~{R},4~{S},5~{S},6~{R})-2-(3,4-dichlorophenyl)sulfanyl-6-(hydroxymethyl)-5-oxidanyl-3-prop-2-ynoxy-oxan-4-yl]oxymethyl]-3-methyl-benzimidazole-5-carboxylic acid
C25 H24 Cl2 N2 O7 S
QFRHUULPFZESGE-BQYMIBSYSA-N
CL
Query on CL

Download Ideal Coordinates CCD File 
D [auth A]CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.08 Å
  • R-Value Free:  0.150 (Depositor), 0.161 (DCC) 
  • R-Value Work:  0.132 (Depositor), 0.148 (DCC) 
  • R-Value Observed: 0.133 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 53.689α = 90
b = 62.28β = 90
c = 84.791γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
Aimlessdata scaling
EDNAdata collection
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
H2020 Marie Curie Actions of the European CommissionEuropean Union765581
European Union (EU)European UnionEUTOPIA PhD Co-tutelle grant
Swedish Research CouncilSweden2020-03317
Swedish Research CouncilSweden2016-04855
Slovenian Research AgencySloveniaP1-0208
Slovenian Research AgencySloveniaJ1-50026
European Cooperation in Science and Technology (COST) actionEuropean UnionCA18103
European Cooperation in Science and Technology (COST) actionEuropean UnionCA18132
European Regional Development FundEuropean UnionOP20.05187 RI-SI-EATRIS

Revision History  (Full details and data files)

  • Version 1.0: 2025-03-12
    Type: Initial release